The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Sean.Cooke@glasgow.ac.uk
pronouns:
He/him/his
Cooke, S. F. et al. (2025) Targeting MDM2 homodimer and heterodimer disruption with DRx-098D in TP53 wild-type and mutant cancer cells. Molecular Therapy Oncology, (doi: 10.1016/j.omton.2025.201029) (Early Online Publication)
O'Gorman, Bria, Cooke, Sean F. and Blair, Connor M. (2025) Precision peptide disruptors: the next generation of targeted therapeutics in oncology. Cellular Signalling, 132, 111783. (doi: 10.1016/j.cellsig.2025.111783)
Cooke, S. F. et al. (2024) Disruption of the pro-oncogenic c-RAF–PDE8A complex represents a differentiated approach to treating KRAS–c-RAF dependent PDAC. Scientific Reports, 14, 8998. (doi: 10.1038/s41598-024-59451-3) (PMID:38637546) (PMCID:PMC11026450)
Cooke, Sean F. and Blair, Connor M. (2024) Exploiting c-RAF dependency in RAS mutant cancer: Beyond catalytic activity. Expert Review of Anticancer Therapy, 24(3-4), pp. 95-100. (doi: 10.1080/14737140.2024.2319035)
Cooke, S. F. et al. (2025) Targeting MDM2 homodimer and heterodimer disruption with DRx-098D in TP53 wild-type and mutant cancer cells. Molecular Therapy Oncology, (doi: 10.1016/j.omton.2025.201029) (Early Online Publication)
O'Gorman, Bria, Cooke, Sean F. and Blair, Connor M. (2025) Precision peptide disruptors: the next generation of targeted therapeutics in oncology. Cellular Signalling, 132, 111783. (doi: 10.1016/j.cellsig.2025.111783)
Cooke, S. F. et al. (2024) Disruption of the pro-oncogenic c-RAF–PDE8A complex represents a differentiated approach to treating KRAS–c-RAF dependent PDAC. Scientific Reports, 14, 8998. (doi: 10.1038/s41598-024-59451-3) (PMID:38637546) (PMCID:PMC11026450)
Cooke, Sean F. and Blair, Connor M. (2024) Exploiting c-RAF dependency in RAS mutant cancer: Beyond catalytic activity. Expert Review of Anticancer Therapy, 24(3-4), pp. 95-100. (doi: 10.1080/14737140.2024.2319035)